Acute Kidney Harm: There have already been postmarketing stories of acute kidney harm and worsening of Persistent renal failure, which may in some cases involve hemodialysis, in individuals addressed with GLP-one receptor agonists. Some events have been described in individuals with no identified underlying renal disorder.This site utilizes cookies